Wissenschaftliche Symposien 2007

Oncogenes meet metabolism - from deregulated genes to a broader understanding of tumour physiology

Dr. Dominik Mumberg, Apoptosis & Signal Transduction Research, Bayer Schering Pharma AG, Berlin, Germany
Dr. T. Steger-Hartmann, Laboratory Diagnostics, Genetics & Ecotoxicology, Bayer Schering Pharma AG, Berlin, Germany
Guido Kroemer, Institut Gustave Roussy, France, Research Director INSERM
Hector Keun, Imperial College, London

Berlin, November 14-16, 2007

pdf Programm als pdf

Sparking signals: kinases as molecular signal transducers and pharmacological drug targets in inflammation

Dr. Arne von Bonin, Dr. Ulrich Zügel, CRBA Inflammation, Bayer Schering Pharma AG, Berlin, Germany
Prof. Dr. Gottfried Baier, Human Genetics Department, Medical University of Innsbruck
Prof. Dr. Burkhart Schraven, Institute for Immunology, University of Magdeburg

Potsdam-Hermannswerder, June 20-22, 2007

pdf Programm als pdf

Organokatalyse

Dr. Hilmar Weinmann, Dr. Stefan Jaroch, Med. Chemistry 1, Bayer Schering Pharma AG, Berlin, Germany
Prof. Manfred T. Reetz, Dr. Benjamin List, Max Planck Institute for Coal Research, Mühlheim/Ruhr

Berlin, 18. - 20. April 2007

pdf Programm als pdf

Progesteron - neueste Erkenntnisse aus Forschung und Praxis

Dr. Dr. Christiane Otto, CRBA Gynecology & Andrology - Female Healthcare, Bayer Schering Pharma AG, Berlin, Germany
Prof. Dr. Orla Conneely, Baylor College, Houston, TX, USA

Berlin, 21. - 23. März 2007

pdf Programm als pdf

Wissenschaftliche Symposien 2007

Oncogenes meet metabolism - from deregulated genes to a broader understanding of tumour physiology

Sparking signals: kinases as molecular signal transducers and pharmacological drug targets in inflammation

Organokatalyse

Progesteron - neueste Erkenntnisse aus Forschung und Praxis

Aktuelles

Ausschreibung: Avrion-Mitchison-Preis der Schering Stiftung 2017

Symposium: Towards a Phenomenology of the Unknown

Lange Nacht der Wissenschaften in der Schering Stiftung